Cocrystal Pharma, Inc. (COCP)
Nasdaq: COCP · Pharmaceutical Preparations · Bothell, WA · filing with the SEC since 2007
Who owns Cocrystal Pharma, Inc.
As filed with the SECHolders of 5% or more
2
OPKO Health, Inc. holds 29.6% of Common Stock, par value $0.001 per share, as its SCHEDULE 13D filed Aug 7, 2026 says.
Directors and officers
10
report now, of 16 people on the record since 2014. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
OPKO Health, Inc.
SCHEDULE 13D · filed Aug 7, 2026 · Common Stock, par value $0.001 per share
Phillip Frost, M.D.
SCHEDULE 13D/A · filed Aug 7, 2026 · Common Stock, par value $0.001 per share · 17.8% in Oct 30, 2025
What COCP reports owning in othersstakes of 5% or more, and other ties
Cocrystal Pharma, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
11purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$300,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 17 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Frost Phillip Md Et Al | director | 0 | $0 | 0 | 11 | $300,000 |